Adjuvant chemotherapy is not associated with a survival benefit for patients with early stage mucinous ovarian carcinoma.

[1]  A. Leary,et al.  Mucinous Ovarian Carcinoma. , 2019, New England Journal of Medicine.

[2]  Ju-Seog Lee,et al.  PRKRA/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer , 2018, Molecular Cancer Therapeutics.

[3]  Deborah DeLair,et al.  Massively parallel sequencing analysis of mucinous ovarian carcinomas: genomic profiling and differential diagnoses. , 2018, Gynecologic oncology.

[4]  A. Haggerty,et al.  Adjuvant chemotherapy for stage I ovarian clear cell carcinoma: Patterns of use and outcomes. , 2018, Gynecologic oncology.

[5]  A. Iasonos,et al.  Comparison of outcomes of primary mucinous ovarian cancer patients receiving either an adjuvant gynecologic or gastrointestinal chemotherapy regimen , 2018, Gynecologic Oncology.

[6]  Does tumor grade influence the rate of lymph node metastasis in apparent early stage ovarian cancer? , 2018, Archives of Gynecology and Obstetrics.

[7]  C. Genestie,et al.  Characteristics and Prognosis of Stage I Ovarian Mucinous Tumors According to Expansile or Infiltrative Type. , 2018, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

[8]  A. Iasonos,et al.  International study of primary mucinous ovarian carcinomas managed at tertiary medical centers , 2015 .

[9]  I. Nagtegaal,et al.  Relatively Poor Survival of Mucinous Ovarian Carcinoma in Advanced Stage: A Systematic Review and Meta-analysis , 2017, International Journal of Gynecologic Cancer.

[10]  M. Birrer,et al.  Outcomes of Women With High-Grade and Low-Grade Advanced-Stage Serous Epithelial Ovarian Cancer. , 2017, Obstetrics and gynecology.

[11]  E. Chapman-Davis,et al.  Prognostic significance of lymphadenectomy and prevalence of lymph node metastasis in clinically-apparent stage I endometrioid and mucinous ovarian carcinoma. , 2017, Gynecologic oncology.

[12]  P. Sabbatini,et al.  Ovarian cancer, version 1.2016: Clinical practice guidelines in oncology , 2016 .

[13]  T. Perren.  Mucinous epithelial ovarian carcinoma. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  Jae-Weon Kim,et al.  Gynecologic Cancer InterGroup (GCIG) Consensus Review for Mucinous Ovarian Carcinoma , 2014, International Journal of Gynecologic Cancer.

[15]  P. Neven,et al.  Primary invasive mucinous ovarian carcinoma of the intestinal type: importance of the expansile versus infiltrative type in predicting recurrence and lymph node metastases. , 2013, European journal of cancer.

[16]  C. Sessa,et al.  Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[17]  R. Soslow.  Mucinous ovarian carcinoma: Slippery business , 2011, Cancer.

[18]  B. Weber,et al.  Mucinous advanced epithelial ovarian carcinoma: clinical presentation and sensitivity to platinum-paclitaxel-based chemotherapy, the GINECO experience. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[19]  B. Monk,et al.  The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: an exploratory analysis of a Gynecologic Oncology Group study. , 2010, Gynecologic oncology.

[20]  C. Ko,et al.  The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United States , 2008, Annals of Surgical Oncology.

[21]  M. Parmar,et al.  International Collaborative Ovarian Neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer. , 2003, Journal of the National Cancer Institute.

[22]  M. Franchi,et al.  Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial. , 2003, Journal of the National Cancer Institute.

[23]  M. Parmar,et al.  International Collaborative Ovarian Neoplasm Trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm Trial: Two Parallel Randomized Phase III Trials of Adjuvant Chemotherapy in Patients With Early-Stage Ovarian Carcinoma. , 2003, Journal of the National Cancer Institute.